Structural Origins for the Product Specificity of SET Domain Protein Methyltransferases
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Plant SET Domain-Containing Proteins: Structure, Function and Regulation
Biochimica et Biophysica Acta 1769 (2007) 316–329 www.elsevier.com/locate/bbaexp Review Plant SET domain-containing proteins: Structure, function and regulation Danny W-K Ng, Tao Wang, Mahesh B. Chandrasekharan 1, Rodolfo Aramayo, ⁎ Sunee Kertbundit 2, Timothy C. Hall Institute of Developmental and Molecular Biology and Department of Biology, Texas A&M University, College Station, TX 77843-3155, USA Received 27 October 2006; received in revised form 3 April 2007; accepted 4 April 2007 Available online 12 April 2007 Abstract Modification of the histone proteins that form the core around which chromosomal DNA is looped has profound epigenetic effects on the accessibility of the associated DNA for transcription, replication and repair. The SET domain is now recognized as generally having methyltransferase activity targeted to specific lysine residues of histone H3 or H4. There is considerable sequence conservation within the SET domain and within its flanking regions. Previous reviews have shown that SET proteins from Arabidopsis and maize fall into five classes according to their sequence and domain architectures. These classes generally reflect specificity for a particular substrate. SET proteins from rice were found to fall into similar groupings, strengthening the merit of the approach taken. Two additional classes, VI and VII, were established that include proteins with truncated/ interrupted SET domains. Diverse mechanisms are involved in shaping the function and regulation of SET proteins. These include protein–protein interactions through both intra- and inter-molecular associations that are important in plant developmental processes, such as flowering time control and embryogenesis. Alternative splicing that can result in the generation of two to several different transcript isoforms is now known to be widespread. -
A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated. -
Targeting the Methyltransferase SETD8 Impairs Tumor Cell Survival and Overcomes Drug Resistance Independently of P53 Status in Multiple Myeloma
bioRxiv preprint doi: https://doi.org/10.1101/776930; this version posted September 20, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Targeting the methyltransferase SETD8 impairs tumor cell survival and overcomes drug resistance independently of p53 status in multiple myeloma Laurie Herviou (1,2,4), Fanny Izard (3,4), Ouissem Karmous-Gadacha (2) , Claire Gourzones (1), Celine Bellanger (1), Eva Desmedt (5), Anqi Ma (6), Laure Vincent (7) , Guillaume Cartron (4,7), Karin Vanderkerken (5), Jian Jin (6), Elke De Bruyne (5), Charlotte Grimaud (3,4,8), Eric Julien (3,4,8 +) and Jérôme Moreaux (1,2,4+) (1) IGH, CNRS, Univ Montpellier, France (2) CHU Montpellier, Laboratory for Monitoring Innovative Therapies, Department of Biological Hematology, Montpellier, France (3) Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Institut Régional du Cancer (ICM), Montpellier F-34298, France (4) University of Montpellier, Montpellier, F-34090, France (5) Department of Hematology and Immunology-Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, Belgium (6) Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, NeW York, NeW York 10029, United States. (7) CHU Montpellier, Department of Clinical Hematology, Montpellier, France (8) Centre National de la Recherche Scientifique (CNRS), F-34293, Montpellier, France + : co-last and corresponding authors ; corresponding authors: Eric Julien ([email protected]) and jérôme Moreaux ([email protected]). 1 bioRxiv preprint doi: https://doi.org/10.1101/776930; this version posted September 20, 2019. -
TRCP Promotes Cell Growth by Targeting PR-Set7/Set8 for Degradation
SCFβ-TRCP promotes cell growth by targeting PR-Set7/Set8 for degradation The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Wang, Z., X. Dai, J. Zhong, H. Inuzuka, L. Wan, X. Li, L. Wang, et al. 2015. “SCFβ-TRCP promotes cell growth by targeting PR-Set7/Set8 for degradation.” Nature Communications 6 (1): 10185. doi:10.1038/ ncomms10185. http://dx.doi.org/10.1038/ncomms10185. Published Version doi:10.1038/ncomms10185 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:23993465 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA ARTICLE Received 4 May 2015 | Accepted 12 Nov 2015 | Published 15 Dec 2015 DOI: 10.1038/ncomms10185 OPEN SCFb-TRCP promotes cell growth by targeting PR-Set7/Set8 for degradation Zhiwei Wang1,2,*, Xiangpeng Dai2,*, Jiateng Zhong2,3,*, Hiroyuki Inuzuka2, Lixin Wan2, Xiaoning Li2,4, Lixia Wang1, Xiantao Ye1, Liankun Sun4, Daming Gao2,5,LeeZou6 & Wenyi Wei2 The Set8/PR-Set7/KMT5a methyltransferase plays critical roles in governing transcriptional regulation, cell cycle progression and tumorigenesis. Although CRL4Cdt2 was reported to regulate Set8 stability, deleting the PIP motif only led to partial resistance to ultraviolet- induced degradation of Set8, indicating the existence of additional E3 ligase(s) controlling Set8 stability. Furthermore, it remains largely undefined how DNA damage-induced kinase cascades trigger the timely destruction of Set8 to govern tumorigenesis. -
Automethylation of PRC2 Promotes H3K27 Methylation and Is Impaired in H3K27M Pediatric Glioma
Downloaded from genesdev.cshlp.org on October 5, 2021 - Published by Cold Spring Harbor Laboratory Press Automethylation of PRC2 promotes H3K27 methylation and is impaired in H3K27M pediatric glioma Chul-Hwan Lee,1,2,7 Jia-Ray Yu,1,2,7 Jeffrey Granat,1,2,7 Ricardo Saldaña-Meyer,1,2 Joshua Andrade,3 Gary LeRoy,1,2 Ying Jin,4 Peder Lund,5 James M. Stafford,1,2,6 Benjamin A. Garcia,5 Beatrix Ueberheide,3 and Danny Reinberg1,2 1Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York 10016, USA; 2Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, USA; 3Proteomics Laboratory, New York University School of Medicine, New York, New York 10016, USA; 4Shared Bioinformatics Core, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA; 5Department of Biochemistry and Molecular Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA The histone methyltransferase activity of PRC2 is central to the formation of H3K27me3-decorated facultative heterochromatin and gene silencing. In addition, PRC2 has been shown to automethylate its core subunits, EZH1/ EZH2 and SUZ12. Here, we identify the lysine residues at which EZH1/EZH2 are automethylated with EZH2-K510 and EZH2-K514 being the major such sites in vivo. Automethylated EZH2/PRC2 exhibits a higher level of histone methyltransferase activity and is required for attaining proper cellular levels of H3K27me3. While occurring inde- pendently of PRC2 recruitment to chromatin, automethylation promotes PRC2 accessibility to the histone H3 tail. Intriguingly, EZH2 automethylation is significantly reduced in diffuse intrinsic pontine glioma (DIPG) cells that carry a lysine-to-methionine substitution in histone H3 (H3K27M), but not in cells that carry either EZH2 or EED mutants that abrogate PRC2 allosteric activation, indicating that H3K27M impairs the intrinsic activity of PRC2. -
H4K20 Monomethylation Faces the WNT
COMMENTARY H4K20 monomethylation faces the WNT Gunnar Schotta1 Munich Center for Integrated Protein Science and Adolf Butenandt Institute, Ludwig Maximilians University, 80336 Munich, Germany rowth factor signaling pathways regulate a broad spectrum of G cellular processes ranging from proliferation to differentiation and tissue homeostasis. Activation of a signaling pathway ultimately leads to transcriptional changes in specific target genes. Although the molecular identities of many signaling pathway components have been revealed over the last years, there is still very little knowledge of how these components induce changes in the chromatin structure of target genes, a re- quirement for activation or repression of these genes. A new link is provided by an interesting paper in PNAS that demon- strates that in the context of Wnt signaling the histone methyltransferase SETD8 (PR-SET7, KMT5a, SET8) is recruited Fig. 1. Wnt signaling stimulates SETD8-mediated H4K20me1 at TCF/LEF binding sites (TBEs). (A)Inthe to enhancer regions of Wnt-regulated absence of Wnt ligand, cellular β-catenin is destabilized and cannot enter the nucleus. Wnt target genes genes. SETD8 establishes H4K20 mono- are constitutively bound by TCF/LEF transcription factors; however, transcription is blocked by binding of methylation (H4K20me1) at these regula- the repressor protein Groucho. (B) Under active Wnt signaling, β-catenin can enter the nucleus and tory regions, which is crucial for full displace Groucho from TCF/LEF. This allows for complex formation with the histone methyltransferase activation of these target genes (1). SETD8, which induces H4K20me1 at TBEs. Increased H4K20me1 is a prerequisite for full transcriptional The canonical Wnt signaling pathway activity of the Wnt target gene, possibly due to recruitment of currently unknown binding proteins. -
Engaging Chromatin: PRC2 Structure Meets Function
www.nature.com/bjc REVIEW ARTICLE Engaging chromatin: PRC2 structure meets function Paul Chammas1, Ivano Mocavini1 and Luciano Di Croce1,2,3 Polycomb repressive complex 2 (PRC2) is a key epigenetic multiprotein complex involved in the regulation of gene expression in metazoans. PRC2 is formed by a tetrameric core that endows the complex with histone methyltransferase activity, allowing it to mono-, di- and tri-methylate histone H3 on lysine 27 (H3K27me1/2/3); H3K27me3 is a hallmark of facultative heterochromatin. The core complex of PRC2 is bound by several associated factors that are responsible for modulating its targeting specificity and enzymatic activity. Depletion and/or mutation of the subunits of this complex can result in severe developmental defects, or even lethality. Furthermore, mutations of these proteins in somatic cells can be drivers of tumorigenesis, by altering the transcriptional regulation of key tumour suppressors or oncogenes. In this review, we present the latest results from structural studies that have characterised PRC2 composition and function. We compare this information with data and literature for both gain-of function and loss-of-function missense mutations in cancers to provide an overview of the impact of these mutations on PRC2 activity. British Journal of Cancer (2020) 122:315–328; https://doi.org/10.1038/s41416-019-0615-2 BACKGROUND and embryonic ectoderm development (EED) (Table 1). These Transcriptional diversity is one of the hallmarks of cellular three proteins form the minimal core that confers histone identity. It is largely regulated at the level of chromatin, where methyltransferase (HMT) activity. A fourth factor, retinoblastoma- different protein complexes act as initiators, enhancers and/or binding protein (RBBP)4/7 (also known as RBAP48/46), has a repressors of transcription. -
Mechanism of CRL4 , a PCNA-Dependent E3 Ubiquitin Ligase
Downloaded from genesdev.cshlp.org on September 27, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Mechanism of CRL4Cdt2, a PCNA-dependent E3 ubiquitin ligase Courtney G. Havens and Johannes C. Walter1 Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA Eukaryotic cell cycle transitions are driven by E3 ubiq- the ubiquitin is transferred from E1 to the cysteine of an uitin ligases that catalyze the ubiquitylation and destruc- ‘‘E2’’ ubiquitin-conjugating enzyme. Finally, the E2 in- tion of specific protein targets. For example, the anaphase- teracts with an ‘‘E3’’ ubiquitin ligase that also binds the promoting complex/cyclosome (APC/C) promotes the substrate. The juxtaposition of the substrate and the charged exit from mitosis via destruction of securin and mitotic E2 enzyme leads to ubiquitin transfer to the substrate. cyclins, whereas CRL1Skp2 allows entry into S phase by The specificity of ubiquitylation is encoded at the level of targeting the destruction of the cyclin-dependent kinase substrate recognition by the E3 enzymes (Ravid and (CDK) inhibitor p27. Recently, an E3 ubiquitin ligase Hochstrasser 2008); however, recently it has become called CRL4Cdt2 has been characterized, which couples clear that E2s can also contribute to processivity and proteolysis to DNA synthesis via an unusual mechanism specificity for ubiquitin chain nucleation and elongation that involves display of substrate degrons on the DNA (Jin et al. 2008; Ye and Rape 2009; Rodrigo-Brenni et al. polymerase processivity factor PCNA. Through its de- 2010; Saha et al. 2011; Wickliffe et al. 2011). Generally, struction of Cdt1, p21, and Set8, CRL4Cdt2 has emerged as the E3–substrate interaction involves the binding of a master regulator that prevents rereplication in S phase. -
Novel Pharmacological Maps of Protein Lysine Methyltransferases: Key for Target Deorphanization Obdulia Rabal* , Andrea Castellar and Julen Oyarzabal*
Rabal et al. J Cheminform (2018) 10:32 https://doi.org/10.1186/s13321-018-0288-5 RESEARCH ARTICLE Open Access Novel pharmacological maps of protein lysine methyltransferases: key for target deorphanization Obdulia Rabal* , Andrea Castellar and Julen Oyarzabal* Abstract Epigenetic therapies are being investigated for the treatment of cancer, cognitive disorders, metabolic alterations and autoinmune diseases. Among the diferent epigenetic target families, protein lysine methyltransferases (PKMTs), are especially interesting because it is believed that their inhibition may be highly specifc at the functional level. Despite its relevance, there are currently known inhibitors against only 10 out of the 50 SET-domain containing members of the PKMT family. Accordingly, the identifcation of chemical probes for the validation of the therapeutic impact of epigenetic modulation is key. Moreover, little is known about the mechanisms that dictate their substrate specifc- ity and ligand selectivity. Consequently, it is desirable to explore novel methods to characterize the pharmacologi- cal similarity of PKMTs, going beyond classical phylogenetic relationships. Such characterization would enable the prediction of ligand of-target efects caused by lack of ligand selectivity and the repurposing of known compounds against alternative targets. This is particularly relevant in the case of orphan targets with unreported inhibitors. Here, we frst perform a systematic study of binding modes of cofactor and substrate bound ligands with all available SET domain-containing PKMTs. Protein ligand interaction fngerprints were applied to identify conserved hot spots and contact-specifc residues across subfamilies at each binding site; a relevant analysis for guiding the design of novel, selective compounds. Then, a recently described methodology (GPCR-CoINPocket) that incorporates ligand contact information into classical alignment-based comparisons was applied to the entire family of 50 SET-containing proteins to devise pharmacological similarities between them. -
Understanding the Histone DNA Repair Code: H4k20me2 Makes Its Mark
Author Manuscript Published OnlineFirst on June 1, 2018; DOI: 10.1158/1541-7786.MCR-17-0688 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Regulation and Function of H4K20me2 in DNA Repair Understanding the histone DNA repair code: H4K20me2 makes its mark Karissa L. Paquina and Niall G. Howletta,1 aDepartment of Cell and Molecular Biology, University of Rhode Island, Kingston, Rhode Island, U.S.A 1Corresponding author: Niall G. Howlett Ph.D., 379 Center for Biotechnology and Life Sciences, 120 Flagg Road, Kingston, RI, USA, Tel.: +1 401 874 4306; Fax: +1 401 874 2065; Email address: [email protected] Keywords: H4K20me2, DNA DSB repair, histone posttranslational modification, homologous recombination, nonhomologous DNA end joining The authors declare no potential conflicts of interest 1 Downloaded from mcr.aacrjournals.org on September 26, 2021. © 2018 American Association for Cancer Research. Author Manuscript Published OnlineFirst on June 1, 2018; DOI: 10.1158/1541-7786.MCR-17-0688 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Regulation and Function of H4K20me2 in DNA Repair Abstract Chromatin is a highly compact structure that must be rapidly rearranged in order for DNA repair proteins to access sites of damage and facilitate timely and efficient repair. Chromatin plasticity is achieved through multiple processes, including the post- translational modification of histone tails. In recent years, the impact of histone post- translational modification on the DNA damage response has become increasingly well recognized, and chromatin plasticity has been firmly linked to efficient DNA repair. -
Structural Chemistry of Human SET Domain Protein Methyltransferases Matthieu Schapira*,1,2
Current Chemical Genomics, 2011, 5, (Suppl 1-M5) 85-94 85 Open Access Structural Chemistry of Human SET Domain Protein Methyltransferases Matthieu Schapira*,1,2 1Structural Genomics Consortium, University of Toronto, MaRS Centre, Toronto, Ontario, M5G 1L7, Canada 2 Department of Pharmacology and Toxicology, University of Toronto, Medical Sciences Building, Toronto, Ontario, M5S 1A8, Canada Abstract: There are about fifty SET domain protein methyltransferases (PMTs) in the human genome, that transfer a methyl group from S-adenosyl-L-methionine (SAM) to substrate lysines on histone tails or other peptides. A number of structures in complex with cofactor, substrate, or inhibitors revealed the mechanisms of substrate recognition, methylation state specificity, and chemical inhibition. Based on these structures, we review the structural chemistry of SET domain PMTs, and propose general concepts towards the development of selective inhibitors. Keywords: Methyltransferase, SET domain, structure, PMT, histone, epigenetics. INTRODUCTION activity, but sometimes recognize the methylation substrate or reaction product. For instance, it was shown that an An- Epigenetics mechanisms rely extensively on histone- kyrin repeat distinct from the catalytic domain of GLP could mediated signaling, in which chemical modifications can recognize mono- or di-methylated lysine 9 of histone 3, the make or break complex biological circuits [1, 2]. Among the very reaction product of GLP’s SET domain [16]. different histone marks, methylation of specific lysine and arginine side-chains can regulate chromatin compaction, As previously observed for histone deacetylases and his- repress or activate transcription, and control cellular differ- tone acetyltransferases, it is becoming clear that histones are entiation [3, 4]. The transfer of a methyl group from the co- not the only subtrates of some PMTs. -
Histone 4 Lysine 20 Methylation: a Case for Neurodevelopmental Disease
biology Review Histone 4 Lysine 20 Methylation: A Case for Neurodevelopmental Disease Rochelle N. Wickramasekara and Holly A. F. Stessman * Department of Pharmacology, School of Medicine, Creighton University, Omaha, NE 68178, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-402-280-2255 Received: 28 December 2018; Accepted: 26 February 2019; Published: 3 March 2019 Abstract: Neurogenesis is an elegantly coordinated developmental process that must maintain a careful balance of proliferation and differentiation programs to be compatible with life. Due to the fine-tuning required for these processes, epigenetic mechanisms (e.g., DNA methylation and histone modifications) are employed, in addition to changes in mRNA transcription, to regulate gene expression. The purpose of this review is to highlight what we currently know about histone 4 lysine 20 (H4K20) methylation and its role in the developing brain. Utilizing publicly-available RNA-Sequencing data and published literature, we highlight the versatility of H4K20 methyl modifications in mediating diverse cellular events from gene silencing/chromatin compaction to DNA double-stranded break repair. From large-scale human DNA sequencing studies, we further propose that the lysine methyltransferase gene, KMT5B (OMIM: 610881), may fit into a category of epigenetic modifier genes that are critical for typical neurodevelopment, such as EHMT1 and ARID1B, which are associated with Kleefstra syndrome (OMIM: 610253) and Coffin-Siris syndrome (OMIM: 135900), respectively. Based on our current knowledge of the H4K20 methyl modification, we discuss emerging themes and interesting questions on how this histone modification, and particularly KMT5B expression, might impact neurodevelopment along with current challenges and potential avenues for future research.